Second-Line Bismuth-Containing Quadruple Therapy for <i>Helicobacter</i><i>pylori</i> Infection: A 12-Year Study of Annual Eradication Rates.

Shin, Kiwon; Cho, Min-Jae; Oh, Jung-Hwan; Lim, Chul-Hyun

Second-Line Bismuth-Containing Quadruple Therapy for Helicobacterpylori Infection: A 12-Year Study of Annual Eradication Rates.

Shin, Kiwon; Cho, Min-Jae; Oh, Jung-Hwan; Lim, Chul-Hyun.

Afiliação

Shin K; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Cho MJ; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Oh JH; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Lim CH; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

J Clin Med ; 10(15)2021 Jul 24.

Article em En | MEDLINE | ID: mdl-34362057

Palavras-chave

Helicobacter pylori; bismuth; breath test; duration of therapy; eradication

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: J Clin Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google